Kinetics of Disopyramide after Intravenous Infusion to Patients with Myocardial Infarction and Heart Failure-Reference-Cited by-同舟云学术

Kinetics of Disopyramide after Intravenous Infusion to Patients with Myocardial Infarction and Heart Failure

Published:2009-03-13 Issue:4 Volume:56 Page:278-282
ISSN:0001-6683
Container-title:Acta Pharmacologica et Toxicologica
language:en
Short-container-title:

Author:

Bonde Jan,Angelo Helle R.,Bødtker Søren,Svendsen Tage Lysbo,Kampmann Jens P.

Publisher

Wiley

Subject

Pharmacology,Toxicology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0773.1985.tb01290.x/fullpdf

Reference13 articles.

1. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans;Aitio;Int. J. Clin. Pharmacol.,1982

2. Disopyramide pharmacokinetics during recovery from myocardial infarction;Bryson;Brit. J. Clin. Pharmacol.,1982

3. Plasma concentration and effect of disopyramide and its mono dealkylated metabolite administered to healthy subjects;Chiang;Brit. J. Clin. Pharmacol.,1982

4. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate;Deano;Chest,1977

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure as a risk factor of adverse drug reactions. Part 2: potential changes in pharmacokinetics of some drugs;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2022-02-13

2. The influence of heart failure on the pharmacokinetics of cardiovascular and non‐cardiovascular drugs: a critical appraisal of the evidence;British Journal of Clinical Pharmacology;2018-10-14

3. Clinical Pharmacokinetics of Drugs in Patients with Heart Failure;Clinical Pharmacokinetics;2013-01-24

4. Decreased vancomycin clearance in patients with congestive heart failure;European Journal of Clinical Pharmacology;2012-07-12

5. Effects of cardiovascular disease on pharmacokinetics;Cardiovascular Drugs and Therapy;1989-09